Pfizer to pay $11.6 bn for Biohaven Pharmaceutical to tap migraine market ...Middle East

Business Standard - Economy
Pfizer will pay $148.50 a share for all of New Haven, Connecticut-based Biohaven's outstanding stock, according to a statement Tuesday

Hence then, the article about pfizer to pay 11 6 bn for biohaven pharmaceutical to tap migraine market was published today ( ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Pfizer to pay $11.6 bn for Biohaven Pharmaceutical to tap migraine market )

Apple Storegoogle play

Last updated :

Also on site :



Latest News